Common Stock SEC Reporting - Current
Verified Company Profile 7/27/2017
Contact Info
  • co Shandong Spring Pharmaceutical Co.
  • Economic Development Zone
  • Gucheng Road, Sishui County
  • Shandong Province 373200
  • China

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0000847464
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: FL, USA
Year of Inc. 1989
Employees 312 a/o Mar 31, 2017
Company Officers/Contacts
Yan Tinghe CEO
Li Chuanmin CFO
Zecheng Shao Vice President, IR
Maogang Sun Gen. Manager
Company Directors
Yan Tinghe Chairman
Robert Fanella
Zhang Jirui
Dong Li
Zhang Wengao
Company Notes
  • Formerly=itLinkz Group, Inc. until 11-07
  • Formerly=Medical Technology & Innovations, Inc. until 4-07
  • Formerly=Southstar Productions, Inc. until 9-95
Service Providers
Accounting/Auditing Firm
Paritz & Company, P.A.
15 Warren St.
Suite 25
Hackensack, NJ, 07601
United States

Legal Counsel
McLaughlin & Stern, LLP
260 Madison Avenue
New York, NY, 10016
United States

Investor Relations Firm
Not Available
CYIG Security Details
Share Structure
Market Value1 $11,915,667 a/o Dec 14, 2017
Authorized Shares 100,000,000 a/o Jun 20, 2017
Outstanding Shares 29,789,168 a/o Aug 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 20,126,227 a/o Jun 20, 2017
Par Value No Par Value
Transfer Agent(s)
Interwest Transfer Co., Inc.
Shareholders of Record 27 a/o Jun 29, 2017
Short Selling Data
Short Interest 0 (-100%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security